LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 1 | 4.24 | 21.74 | 760 | 317 | 2.3915 | 1.5055 | MN20160310_N01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 6.21 | 21.74 | 674 | 392 | 1.7194 | 1.2774 | MN20160310_N01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 6.21 | 21.74 | 802 | 392 | 2.0459 | 1.3743 | MN20160310_N01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 8.19 | 21.74 | 8 | 439 | 0.0182 | -0.2058 | MN20160310_N01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 8.19 | 21.74 | 725 | 439 | 1.6483 | 1.2441 | MN20160310_N01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 8.19 | 21.74 | 1 | 439 | 0.0023 | -0.5082 | MN20160310_N01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 8.19 | 21.74 | 860 | 439 | 1.9552 | 1.3342 | MN20160310_N01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 10.16 | 21.74 | 10 | 463 | 0.0216 | -0.1613 | MN20160310_N01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 10.16 | 21.74 | 766 | 463 | 1.6521 | 1.2409 | MN20160310_N01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 10.16 | 21.74 | 1 | 463 | 0.0022 | -0.5022 | MN20160310_N01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 10.16 | 21.74 | 901 | 463 | 1.9433 | 1.3248 | MN20160310_N01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 12.13 | 21.74 | 12 | 496 | 0.0242 | -0.1234 | MN20160310_N01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 12.13 | 21.74 | 793 | 496 | 1.5976 | 1.2188 | MN20160310_N01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 12.13 | 21.74 | 1 | 496 | 0.0020 | -0.4945 | MN20160310_N01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 12.13 | 21.74 | 930 | 496 | 1.8737 | 1.2985 | MN20160310_N01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 14.10 | 21.74 | 14 | 540 | 0.0259 | -0.0905 | MN20160310_N01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 14.10 | 21.74 | 807 | 540 | 1.4919 | 1.1802 | MN20160310_N01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 14.10 | 21.74 | 7 | 540 | 0.0129 | -0.2168 | MN20160310_N01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 14.10 | 21.74 | 942 | 540 | 1.7414 | 1.2542 | MN20160310_N01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 16.07 | 21.74 | 1 | 597 | 0.0017 | -0.4748 | MN20160310_N01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 16.07 | 21.74 | 788 | 597 | 1.3180 | 1.1189 | MN20160310_N01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 16.07 | 21.74 | 14 | 597 | 0.0234 | -0.0879 | MN20160310_N01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 16.07 | 21.74 | 951 | 597 | 1.5907 | 1.2039 | MN20160310_N01 | H08 |